Loading…
Simple
Expanded
Grid
By Venue
arrow_back View All Dates
Wednesday, September 25
 

8:00am PDT

Registration and Networking Breakfast
Wednesday September 25, 2024 8:00am - 8:45am PDT
San Diego Marriott Del Mar
Wednesday September 25, 2024 8:00am - 8:45am PDT
San Diego Marriott Del Mar
  Networking

8:45am PDT

Chairperson’s Opening Remarks
Wednesday September 25, 2024 8:45am - 9:00am PDT
San Diego Marriott Del Mar
Speakers
avatar for Ralph Rewers

Ralph Rewers

Executive Director, Medical Sciences, US Medical Affairs, Gilead Sciences
Ralph is a creative, achievement oriented professional with established performance at six pharma/biotech companies, progressing from a field based medical role to senior leadership level positions in more than 12 different therapeutic areas. Proven ability to create functions and... Read More →
Wednesday September 25, 2024 8:45am - 9:00am PDT
San Diego Marriott Del Mar
  General Session

9:00am PDT

Driving Diversity and Patient-Centric Innovation: The Transformative Role of Medical Affairs
Wednesday September 25, 2024 9:00am - 9:30am PDT
San Diego Marriott Del Mar
  • Explore the essential benchmarks for building high-performing Medical Affairs teams throughout the drug development process
  • Discuss effective strategies for reflecting corporate values in Medical Affairs initiatives to ensure alignment with organizational mission and ethics
  • Highlight how Medical Affairs can drive efforts in diversity, inclusion, and patient-centricity to enhance overall healthcare outcomes and patient engagement
Speakers
avatar for Richey Neuman, M.D., M.P.H.

Richey Neuman, M.D., M.P.H.

Vice President of Medical Affairs, Cytokinetics
Richey serves as Vice President of Medical Affairs, and joined Cytokinetics in February 2020.Prior to Cytokinetics, Richey held Vice President of Medical Affairs positions at MyoKardia, Portola, Hyperion, and Teva. Before joining the pharmaceutical industry in 2006, Richey was on... Read More →
Wednesday September 25, 2024 9:00am - 9:30am PDT
San Diego Marriott Del Mar
  General Session

9:30am PDT

Mastering AI in Medical Affairs: From Strategy to Impact
Wednesday September 25, 2024 9:30am - 10:00am PDT
San Diego Marriott Del Mar
  • Acknowledge where most medical affairs teams currently stand in their journey towards the ideal state of AI integration, comparing the "dreamland" vision with the practical realities of today's processes and technologies.
  • Discuss the real-world applications and key lessons learned from Gen AI's rapid evolution over the past two years, including how AI has been utilized in various aspects of medical affairs, such as field insights, lit review, med education , all contributing to strategic insights.
  • Explore actionable steps teams can take today to transform insights into impactful strategies, emphasizing the importance of selecting the right tools—whether internal solutions like enterprise GPT or external vendors—and implementing change management processes to achieve desired outcomes
Speakers
avatar for Vera Kutsenko

Vera Kutsenko

Founder & CEO, Atrix AI
Vera Kutsenko is the CEO of Atrix AI. Atrix helps medical affairs teams measure the impact of their medical strategy across field, med education, med info, and more. Vera brings over 10 years of experience in the technology industry across AI, global and secure distributed systems... Read More →
avatar for Carl de Luca, PhD

Carl de Luca, PhD

Regeneron
Carl de Luca, PhD, is a distinguished professional in the field of medical affairs with a robust background in oncology. He earned his PhD from Columbia University, where he developed a strong foundation in medical research and scientific inquiry. Dr. de Luca began his career in... Read More →
Wednesday September 25, 2024 9:30am - 10:00am PDT
San Diego Marriott Del Mar
  General Session

10:00am PDT

Driving Value from Development Through Delivery: The Essential Role of Medical Affairs in Bridging Clinical and Commercial Divides
Wednesday September 25, 2024 10:00am - 10:45am PDT
  • Examine how medical affairs sits as the crucial third pillar between clinical and commercial functions, harnessing the strengths of both sides to deliver enhanced value to stakeholders 
  • Explore the dynamics of successful collaborations between medical and commercial teams, emphasizing the importance of mutual understanding, communication and shared goals 
  • Understand the significance of defining success metrics, tracking collabortative efforts, and fostering a culture of innovation within regulated environments to drive continual improvement 
Moderators
avatar for Patricia Novy

Patricia Novy

Vice President of Medical Affairs, Dynavax
Dr. Novy joined Dynavax in 2021 and currently serves as Vice President, Medical Affairs. She comes to the company with more than 10 years of experience in the vaccines field. Dr. Novy joined Dynavax from Moderna, where she was Senior Director, Global Medical Affairs, responsible for... Read More →
Speakers
avatar for Mancia Ko, PharmD, MBA,

Mancia Ko, PharmD, MBA,

Vice President Medical Affairs, Collegium Pharmaceutical
 Mancia Ko has diverse experience in Medical Affairs, Medical Communications, Regulatory Affairs, Market Access, and Business Development. She is currently the Vice President of Medical Affairs at Collegium Pharmaceutical, where her strategic thinking and agility have been transformative... Read More →
avatar for Scott McConnell

Scott McConnell

Vice President Clinical Science and Pharmacovigilance, Xilio Therapeutics
Scott McConnell, Pharm.D. is currently the VP of Clinical Sciences and Pharmacovigilance at Xilio Therapeutics. He has spent the last 19 years in various roles within Medical Affairs at Cubist, Merck, Chiasma (Amryt), Alkermes and Venatorx. Prior to industry he spent several years... Read More →
avatar for April Thompson

April Thompson

Vice President, Global Medical Affairs, Otsuka
April Thompson is currently the Vice President of Global Medical Affairs at Otsuka.  April has a career spanning two decades in the pharmaceutical industry. She has worked across a range of therapeutic areas, including Psychiatry, Neurology, Immunology, Hepatology, and Dermatology... Read More →
Wednesday September 25, 2024 10:00am - 10:45am PDT
  General Session
  • QTAG MASSW24FS

10:45am PDT

Networking Break
Wednesday September 25, 2024 10:45am - 11:15am PDT
San Diego Marriott Del Mar
Wednesday September 25, 2024 10:45am - 11:15am PDT
San Diego Marriott Del Mar
  Networking

10:45am PDT

1:1 Curated Meetings
Wednesday September 25, 2024 10:45am - 12:00pm PDT
Rancho Santa Fe Ballroom I&II
Wednesday September 25, 2024 10:45am - 12:00pm PDT
Rancho Santa Fe Ballroom I&II
  1:1 Partner Meetings

11:15am PDT

Roundtables
Wednesday September 25, 2024 11:15am - 12:00pm PDT
San Diego Marriott Del Mar
Optimizing MSL Productivity: Strategies for Success and Retention
  • Discuss practical strategies for showcasing MSL productivity through tangible performance metrics and outcomes
  • Explore insights into fostering a supportive workplace culture to boost MSL retention and career satisfaction
  • Hear ways to utilize technology and innovative tools to streamline MSL activities and enhance overall effectiveness in the field
Lynn Bass, Pharm.D., Senior Director, Medical Science Liaisons, BridgeBio

Measuring Your Omnichannel Impact
  • Define the scope and intricacies of omnichannel strategies in medical affairs.
  • Explore effective methodologies for measuring and evaluating omnichannel success
  • Share challenges faced in implementing and optimizing omnichannel strategies
Stevan Tomich, PharmD, Omnichannel Strategy Lead Oncology, AbbVie 

Integrating Real-World Evidence into Medical Affairs Strategies: Bridging Clinical Development and Field Insights  
  • Address the value of Real-World Evidence (RWE); how this collection of data can help researchers identify the most relevant variables, thereby saving costs and time 
  • Explore how the role of RWE has shifted from a supplementary resource to a more strategic and central component in medical affairs activities and discuss its impact on informing clinical development and decision-making processes.  
  • Examine best practices for MSLs to work effectively with clinical development teams, leveraging RWE to enhance strategic planning, optimize trial designs, and address emerging data needs.  
  • Discuss strategies for efficiently incorporating real-world data into medical affairs practices to meet the increasing requests from stakeholders and improve overall value and patient outcomes.  
Sue Malecha, PharmD, MBA, Senior Director, Medical Affairs, Gilead 
Speakers
avatar for Susan Malecha, PharmD

Susan Malecha, PharmD

Senior Director, Medical Affairs, Gilead
Susan Malecha is a results-driven versatile medical professional with a proven track record for achievement in the pharmaceutical/biotechnology industry. An accomplished author, she has lectured extensively and is called upon to present the latest developments in the areas of Medical... Read More →
Wednesday September 25, 2024 11:15am - 12:00pm PDT
San Diego Marriott Del Mar
  Roundtable Discussions

12:00pm PDT

Integrating Medical Affairs and Patient Advocacy in Early-Stage Biotech: A Blueprint for Agile Drug Development
Wednesday September 25, 2024 12:00pm - 12:30pm PDT
San Diego Marriott Del Mar
Speakers
avatar for Maria Candida Vila, PharmD, MSPH, Ph.D.

Maria Candida Vila, PharmD, MSPH, Ph.D.

Director of Medical Affairs, Encoded Therapeutics
Dr. Maria Candida Vila has over a decade of experience in the medical and scientific arenas. She is currently Director of Medical Affairs at Encoded Therapeutics, where she plays a key role in advancing gene therapies for pediatric CNS disorders. Since joining the company in April... Read More →
Wednesday September 25, 2024 12:00pm - 12:30pm PDT
San Diego Marriott Del Mar
  General Session

12:30pm PDT

Networking Lunch
Wednesday September 25, 2024 12:30pm - 1:30pm PDT
San Diego Marriott Del Mar
Wednesday September 25, 2024 12:30pm - 1:30pm PDT
San Diego Marriott Del Mar
  Networking

1:30pm PDT

Quantifying Impact: Unveiling Metrics That Resonate with Stakeholders
Wednesday September 25, 2024 1:30pm - 2:00pm PDT
San Diego Marriott Del Mar
  • Discuss the importance of identifying and tailoring metrics to the specific needs and perspectives of various stakeholders within the healthcare ecosystem - both internally, including executive management and cross-functional partners, as well as externally, including providers, payors, and patients. 
  • Highlight the significance of clinically relevant metrics to quantify the impact of Medical Affairs strategic and tactical activities, e.g., educational, and one-on-one field engagement activities that potentially reflect improvement by the medical community's understanding of treatment options and the diagnosis of the therapeutic area. 
  • Explore potential real-world data sources, e.g., electronic health records, claims data, and patient-reported outcomes, in quantifying the impact of Medical Affairs activities. Discuss analytics for effectively capturing, analyzing, and interpreting real-world evidence to potentially explain the meaning of insights and to drive better decision-making around Medical Affairs resource allocation. 
Speakers
avatar for Daniel Snyder, Ph.D.

Daniel Snyder, Ph.D.

Senior Vice President, Head of Medical Affairs, Biopharma & Women’s Health, Sumitomo Pharma America, Inc.
Over the past 30 years in the pharmaceutical industry, Daniel Snyder, PhD has delivered Global Medical Affairs excellence during all stages of a drug’s lifecycle and established a record of building Medical Affairs functions from the ground up. He has expertise in building and leading... Read More →
Wednesday September 25, 2024 1:30pm - 2:00pm PDT
San Diego Marriott Del Mar
  General Session
  • QTAG MASSW24FS

2:00pm PDT

Optimizing Medical Affairs Integration: Strategies for Building and Scaling Throughout the Development Cycle
Wednesday September 25, 2024 2:00pm - 2:45pm PDT
San Diego Marriott Del Mar
  • Discuss key stages in drug development where early integration of Medical Affairs teams can optimize product strategy and market access
  • Identify effective strategies for scaling medical affairs capabilities
  • Explore ways to enhance cross-functional collaboration across the product lifecycle
Moderators
avatar for Catherine Ross, PharmD

Catherine Ross, PharmD

Head of Field Medical Affairs, Orca Bio
Catherine Ross is a dynamic, innovative, and compassionate leader who spent almost 10 years as a Pediatric Hematology/Oncology Pharmacist at Children's Healthcare of Atlanta before transitioning to a career in Medical Affairs. She spent 5.5 years at Jazz Pharmaceuticals as a Medical... Read More →
Speakers
avatar for Andrea Goldstein

Andrea Goldstein

Senior Vice President, Global Medical and Scientific Affairs, Mirum Pharmaceuticals
Andrea Goldstein is a pharmaceutical industry veteran with more than 20 years of experience,building medical affairs capabilities, leading drug launches, and bringing new therapies to patientsat both biotech start-ups and large pharmaceutical companies.Andrea has extensive clinical... Read More →
avatar for Eleonora Goldberg, Ph.D.

Eleonora Goldberg, Ph.D.

Vice President Medical Affairs, Arrowhead Pharmaceuticals
Eleonora has extensive experience in Medical Affairs, having strategically developed and transformed Medical Affairs teams at the local, regional, and global level. She has led matrixed and dynamic teams, partnering cross-functionally to enhance the impact and scientific knowledge... Read More →
avatar for Nick Giafis, Ph.D.

Nick Giafis, Ph.D.

Vice President, Head of Medical Affairs, Kura Oncology
Nick Giafis is currently Vice President and Head of Medical Affairs at Kura Oncology. He has over 18 years of experience working in medical affairs roles of progressive responsibility. Previously, he worked at Kronos Bio where he created and led the medical organization. Before Kronos... Read More →
Wednesday September 25, 2024 2:00pm - 2:45pm PDT
San Diego Marriott Del Mar
  General Session

2:45pm PDT

Empowering Medical Affairs: Streamlining Operations with Technology
Wednesday September 25, 2024 2:45pm - 3:15pm PDT
San Diego Marriott Del Mar
  • Automate for Efficiency: Implementing software solutions can automate repetitive tasks, enabling medical affairs teams to prioritize strategic initiatives and value-added activities.
  • Collaborate Seamlessly: Advanced software fosters seamless collaboration among both internal teams and external stakeholders, enhancing communication and optimizing project timelines.
  • Increase Productivity: Leveraging software capabilities allows teams to efficiently manage increased publication outputs and medical information requests, while simultaneously reducing errors and ensuring compliance


Speakers
avatar for David A. Mays, PharmD, MBA

David A. Mays, PharmD, MBA

Global Publications Director, Neuromodulation
avatar for Peter Herout, PharmD

Peter Herout, PharmD

Associate Director, Scientific Communication, Esperion
avatar for Michelle L. Chernock, Ph.D.

Michelle L. Chernock, Ph.D.

Founder and CEO, Leaders in Medical Affairs
Michelle L. Chernock, PhD, is the founder of Leaders in Medical Affairs and MSL University. With more than 20 years of experience in the pharmaceutical industry – from startups to multinationals – Michelle specializes in helping medical affairs leaders develop their careers and... Read More →
Wednesday September 25, 2024 2:45pm - 3:15pm PDT
San Diego Marriott Del Mar
  General Session

3:15pm PDT

Networking Break
Wednesday September 25, 2024 3:15pm - 3:45pm PDT
San Diego Marriott Del Mar
Wednesday September 25, 2024 3:15pm - 3:45pm PDT
San Diego Marriott Del Mar
  Networking

3:15pm PDT

1:1 Curated Meetings
Wednesday September 25, 2024 3:15pm - 4:30pm PDT
Rancho Santa Fe Ballroom I&II
Wednesday September 25, 2024 3:15pm - 4:30pm PDT
Rancho Santa Fe Ballroom I&II
  1:1 Partner Meetings

3:45pm PDT

Roundtables
Wednesday September 25, 2024 3:45pm - 4:30pm PDT
San Diego Marriott Del Mar
Optimizing MSL Productivity: Strategies for Success and Retention
  • Discuss practical strategies for showcasing MSL productivity through tangible performance metrics and outcomes
  • Explore insights into fostering a supportive workplace culture to boost MSL retention and career satisfaction
  • Hear ways to utilize technology and innovative tools to streamline MSL activities and enhance overall effectiveness in the field
Jim Wilkinson, Ph.D., US Medical Lead, Medical Affairs & Evidence Generation, Argenx

Measuring Your Omnichannel Impact
  • Define the scope and intricacies of omnichannel strategies in medical affairs.
  • Explore effective methodologies for measuring and evaluating omnichannel success
  • Share challenges faced in implementing and optimizing omnichannel strategies
Stevan Tomich, PharmD, Omnichannel Strategy Lead Oncology, AbbVie

Integrating Real-World Evidence into Medical Affairs Strategies: Bridging Clinical Development and Field Insights  
  • Address the value of Real-World Evidence (RWE); how this collection of data can help researchers identify the most relevant variables, thereby saving costs and time 
  • Explore how the role of RWE has shifted from a supplementary resource to a more strategic and central component in medical affairs activities and discuss its impact on informing clinical development and decision-making processes.  
  • Examine best practices for MSLs to work effectively with clinical development teams, leveraging RWE to enhance strategic planning, optimize trial designs, and address emerging data needs.  
  • Discuss strategies for efficiently incorporating real-world data into medical affairs practices to meet the increasing requests from stakeholders and improve overall value and patient outcomes.  
Sue Malecha, PharmD, MBA, Senior Director, Medical Affairs, Gilead 


Speakers
avatar for Jim Wilkinson, Ph.D.

Jim Wilkinson, Ph.D.

US Medical Lead, Medical Affairs & Evidence Generation, Argenx
Jim Wilkinson, Ph.D. is currently US Medical Lead, Medical Affairs & Evidence Generation with argenx.Jim is an experienced and innovative leader in global and US Medical Affairs, with over 22 years in the biopharma industry. He has worked in several therapeutic areas while also launching... Read More →
avatar for Susan Malecha, PharmD

Susan Malecha, PharmD

Senior Director, Medical Affairs, Gilead
Susan Malecha is a results-driven versatile medical professional with a proven track record for achievement in the pharmaceutical/biotechnology industry. An accomplished author, she has lectured extensively and is called upon to present the latest developments in the areas of Medical... Read More →
Wednesday September 25, 2024 3:45pm - 4:30pm PDT
San Diego Marriott Del Mar
  Roundtable Discussions

4:30pm PDT

From Strategy to Execution: A Blueprint for Launch Success
Wednesday September 25, 2024 4:30pm - 5:20pm PDT
San Diego Marriott Del Mar
  • Discuss the importance of early collaboration across various functions within the organization, emphasizing how it enhances launch success 
  • Highlight specific strategies and examples of successful integration efforts during different phases of product launch 
  • Examine the importance of aligning launch strategies with therapeutic goals, market dynamics, and available data to maximize MSL effectiveness 
  • Explore effective strategies for measuring success in product launches, including KPI's and metrics 


Moderators
avatar for Arthur Chan, PhD, MBA

Arthur Chan, PhD, MBA

Vice President of Medical Affairs, Tarsus Pharmaceuticals
Arthur Chan is an innovative and respected medical affairs leader with 20 years of experience in pharmaceuticals and medical devices. He has successfully built teams and launched products in many therapeutic areas with a decade of focus in eyecare. Arthur is currently vice president... Read More →
Speakers
avatar for Gail Larkins

Gail Larkins

Executive Director, Global Medical Operations, BioCryst Pharmaceuticals
avatar for Bob Numerof

Bob Numerof

Vice President, Medical Affairs, ALX Oncology
Bob Numerof is currently the Vice President of Medical Affairs at ALX Oncology. Prior to this role at ALX, he has had a number of positions in both small and large pharmaceutical companies which spanned the full scope of medical affairs activities and included both in-house and field-based... Read More →
avatar for Andrea Zider, Ph.D.

Andrea Zider, Ph.D.

Vice President Medical Brand, Medical Affairs, BridgeBio
avatar for Daphne Dodson, Ph.D.

Daphne Dodson, Ph.D.

EVP, Chief Strategy Officer, PIXACORE
avatar for Vanessa Jacobsen, PharmD

Vanessa Jacobsen, PharmD

Senior Director, Field Medical Affairs – Hematology, Regeneron
Vanessa Jacobsen is the Senior Director, Hematology Field Medical Affair at Regeneron.  In her role, Vanessa is responsible for providing leadership in developing and implementing the hematology field medical engagement strategy. Vanessa is a seasoned leader in assessment, development... Read More →
Wednesday September 25, 2024 4:30pm - 5:20pm PDT
San Diego Marriott Del Mar
  General Session

5:20pm PDT

Chairperson’s Closing Remarks
Wednesday September 25, 2024 5:20pm - 5:30pm PDT
San Diego Marriott Del Mar
Speakers
avatar for Ralph Rewers

Ralph Rewers

Executive Director, Medical Sciences, US Medical Affairs, Gilead Sciences
Ralph is a creative, achievement oriented professional with established performance at six pharma/biotech companies, progressing from a field based medical role to senior leadership level positions in more than 12 different therapeutic areas. Proven ability to create functions and... Read More →
Wednesday September 25, 2024 5:20pm - 5:30pm PDT
San Diego Marriott Del Mar
  General Session

5:30pm PDT

Cocktail Reception
Wednesday September 25, 2024 5:30pm - 6:30pm PDT
San Diego Marriott Del Mar
Wednesday September 25, 2024 5:30pm - 6:30pm PDT
San Diego Marriott Del Mar
  Networking
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.
Filtered by Date - 
Clear filter
Wednesday, September 25
Thursday, September 26
Rancho Santa Fe Ballroom I&II
San Diego Marriott Del Mar
  • 1:1 Partner Meetings
  • General Session
  • Networking
  • Roundtable Discussions